Skip to main content
Premium Trial:

Request an Annual Quote

Nebula Genomics Raises $4.3M, Partners With Veritas

NEW YORK (GenomeWeb) – Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said on Wednesday. 

Nebula, which was founded last year by Harvard University researchers including George Church, aims to build a platform on which genomic data can be shared by harnessing blockchain technology.

The startup secured funding from Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures, and Heartbeat Labs, and plans to use the financing to continue building a decentralized marketplace for genomic data.

Under the partnership with Veritas, Nebula will have access to Veritas' open-source software platform, Arvados.

"Our investors, along with Veritas, share our commitment to lowering access barriers to genomic data, and solving one of the primary roadblocks preventing personalized medicine becoming a reality today," Kamal Obbad, CEO and co-founder of Nebula Genomics, said in a statement. 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.